NRX Pharmaceuticals Inc (NRXP)

NASDAQ
10.70
+0.20(+1.90%)
  • Volume:
    1,363,993
  • Bid/Ask:
    10.63/10.73
  • Day's Range:
    10.00 - 10.76

NRXP Overview

Prev. Close
10.5
Day's Range
10-10.76
Revenue
-
Open
10.44
52 wk Range
8.39-76.99
EPS
-7.6
Volume
1,363,993
Market Cap
564.62M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,913,028
P/E Ratio
-
Beta
0.11
1-Year Change
-1.69%
Shares Outstanding
53,773,534
Next Earnings Date
-
What is your sentiment on NRX Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

NRX Pharmaceuticals Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell

NRX Pharmaceuticals Inc Company Profile

NRX Pharmaceuticals Inc Company Profile

Sector
Services
Employees
2

NRX Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company’s pipeline includes medicinal candidates in Phase 2 and Phase 3 trials for COVID-19-related lung injury and acute respiratory distress. Its products include ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure; and NRX-100/101, an investigational pre-commercial drug for treating bipolar depression in patients with acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.